Evidence map›Paper›PMID 39558266›Full record

ArticleBMC public health2024

Community utilization of a co-created COVID-19 testing program in a US/Mexico border community.

Breanna J Reyes, Stephenie Tinoco Calvillo, Arleth A Escoto, Angel Lomeli, Maria Linda Burola, Luis Gay, Ariel Cohen, Isabel Villegas, Linda Salgin, Kelli L Cain and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Breanna J ReyesDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California, La Jolla, San Diego, CA, USA. bjreyes@health.ucsd.edu.
Stephenie Tinoco CalvilloDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California, La Jolla, San Diego, CA, USA.
Arleth A EscotoDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California, La Jolla, San Diego, CA, USA.
Angel LomeliDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California, La Jolla, San Diego, CA, USA.
Maria Linda BurolaDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California, La Jolla, San Diego, CA, USA.
Luis GaySan Ysidro Health, San Ysidro, CA, USA.
Ariel CohenDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California, La Jolla, San Diego, CA, USA.
Isabel VillegasDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California, La Jolla, San Diego, CA, USA.
Linda SalginSan Ysidro Health, San Ysidro, CA, USA.
Kelli L CainHerbert Wertheim School of Public Health and Longevity Science, University of California, La Jolla, San Diego, CA, USA.
Dylan PilzKristian Andersen Lab at The Scripps Research Institute, La Jolla, San Diego, CA, USA.
Paul WatsonThe Global Action Research Center, San Diego, CA, USA.
Bill OswaldThe Global Action Research Center, San Diego, CA, USA.
Cesar ArevaloCounty of San Diego Health and Human Services Agency, San Diego, CA, USA.
Jessica SanchezCounty of San Diego Health and Human Services Agency, San Diego, CA, USA.
Marjorie RichardsonCounty of San Diego Health and Human Services Agency, San Diego, CA, USA.
Jennifer NelsonCounty of San Diego Health and Human Services Agency, San Diego, CA, USA.
Pricilla VillanuevaCounty of San Diego Health and Human Services Agency, San Diego, CA, USA.
Garrett McGaughCounty of San Diego Health and Human Services Agency, San Diego, CA, USA.
Ilya ZaslavskySan Diego Supercomputer Center, University of California, La Jolla, San Diego, CA, USA.
Robert H TukeyLaboratory of Environmental Toxicology, Department of Pharmacology, University of California, La Jolla, San Diego, CA, United States of America.
Nicole A StadnickDepartment of Psychiatry, University of California, La Jolla, San Diego, CA, USA.
Borsika A RabinHerbert Wertheim School of Public Health and Longevity Science, University of California, La Jolla, San Diego, CA, USA.
Louise C LaurentDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California, La Jolla, San Diego, CA, USA.
Marva SeifertDepartment of Medicine, University of California, La Jolla, San Diego, CA, USA.

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
Yeast Genetics and Stress Response Genes-BiomedicalP42ES010337 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TUKEY, ROBERT H · 2000 to 2022
$69.8M
NCATS NIH HHS UL1 TR001442NIEHS NIH HHS P42 ES010337NIH HHS P42ES010337-20S1
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic exposed several health disparities experienced by underserved and Latino/a communities, including inequitable access to COVID-19 testing. OBJECTIVE AND GOALS: To describe the utilization of a community-driven and culturally-tailored testing model on COVID-19 testing in an underserved Latino/a community in San Diego.

methodsThe Community-driven Optimization of COVID-19 testing to Reach and Engage Underserved Areas for Testing Equity (CO-CREATE) project implemented a community co-designed COVID-19 testing program in partnership with a Federally Qualified Health Center in a US/Mexico border community.

resultsBetween May 2021 and March 2023, 24, 422 COVID-19 PCR tests were administered to 13,253 individuals, among whom 93% percent identified as Latino/a, 57% spoke Spanish in the home, and 38% resided in our target community adjacent to the US/Mexico border, San Ysidro. Based on a subset of available county testing data, CO-CREATE accounted for nearly 12% of all COVID-19 tests reported for San Ysidro residents. Over the course of the project, we estimated that nearly 17% of all San Ysidro residents were tested for COVID-19 through the CO-CREATE project.

conclusionThese findings highlight the success and reach of this culturally responsive and community co-designed COVID-19 testing program, within a Latino/a border community. Future public health interventions should focus on identifying testing barriers and design appropriate strategies to ensure equitable access to resources and testing uptake for all community members.

Indexed as

COVID-19COVID-19 TestingHispanic or LatinoAdolescentAdultAgedCaliforniaFemaleHumansMaleMedically Underserved AreaMexicoMiddle AgedYoung AdultBorder communityCo-creationCOVID-19 positivityCOVID-19 testingCulturally responsiveLatino/a

Identifiers

PMID39558266
PMCPMC11572090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.